Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2016-06-03
Summary
A Phase II study to evaluate the safety and efficacy of five dose levels of study drug in acute ischaemic stroke
Conditions
Interventions
- DRUG
-
V10153
Single acute intravenous bolus dose up to 10 mg/kg
Sponsors & Collaborators
-
Vernalis (R&D) Ltd
lead INDUSTRY
Principal Investigators
-
Michael Hill · Foothills Hosptial
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2008-11-30
- Completion
- 2009-03-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
A Study of NCS-01 in Patients With Acute Ischemic Stroke
NCT03915431 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
NCT07279493 ·Status: RECRUITING ·Phase: PHASE2
-
SY007 in Patients With Acute Ischemic Stroke
NCT04891913 ·Status: SUSPENDED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
NCT00046761 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
NCT03346538 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke
NCT02828540 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy
NCT03198715 ·Status: COMPLETED ·Phase: NA
-
Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
NCT05745311 ·Status: UNKNOWN ·Phase: PHASE2
-
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
NCT01273467 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase Ib/II in Patients With Acute Ischemic Stroke
NCT02963376 ·Status: COMPLETED ·Phase: PHASE1
-
Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;
NCT04290494 ·Status: COMPLETED
-
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
NCT02586233 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
NCT05403866 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT05515393 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
NCT04950790 ·Status: UNKNOWN ·Phase: PHASE4
-
Suhexiang Pill for Acute Ischemic Stroke: A Registry Study
NCT05833932 ·Status: RECRUITING
-
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
NCT05068349 ·Status: RECRUITING ·Phase: PHASE4
-
Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial
NCT06447415 ·Status: COMPLETED ·Phase: PHASE1
-
An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
NCT04952064 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
NCT02643784 ·Status: UNKNOWN ·Phase: PHASE4
-
Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults
NCT05547438 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
NCT02059785 ·Status: SUSPENDED ·Phase: PHASE2